Trial Profile
Multicenter Lymphangioleiomyomatosis Long Term Sirolimus Trial
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 06 Jun 2016
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary)
- Indications Lymphangioleiomyomatosis
- Focus Adverse reactions
- Acronyms MLLTS
- 06 Jun 2016 New trial record